Search

everythinglearnresearchcommunity

for

Search:↓

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Trichilemmal carcinoma shares genetic traits with other skin cancers, suggesting similar treatment options.

Trichilemmal carcinoma shares genetic traits with other skin cancers, suggesting similar treatment options.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

Baldness may lower the risk of testicular cancer.

Most inconsolable crying in infants is not due to a serious cause, and a detailed check-up is typically enough to find the reason.

Drug repositioning is a promising way to quickly develop new treatments, especially for rare diseases.

Hormonal therapies are safe and effective for treating adult women's acne.

Finasteride does not prevent bladder cancer.

Horse skin diseases are complex to manage and often require a biopsy for accurate diagnosis and treatment.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

ATP-sensitive K+ channel subunits, particularly Sur2A, play a significant role in various cancers.

Longer TA repeats in the SRD5A2 gene may increase acne risk in Chinese people.

Diagnosing and managing PCOS in teens is hard, but early diagnosis and lifestyle changes are key, and more research is needed for long-term health.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

More high-quality research is needed to recommend flavonoids and saponins for clinical use.

About 40% of women by age 60 experience significant hair loss, often due to androgenetic alopecia, with treatments like minoxidil available and hope for future cures.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Geriatric Julia Creek dunnarts often suffer from reproductive and skin diseases, impacting conservation efforts.

The document describes various skin conditions, their features, and treatments but lacks detailed study size information.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

Keratin protein production in cells is controlled by a complex system that changes with cell type, health, and conditions like injury or cancer.